Active substance
Results for the substance netupitant+palonosetron
1 result
About this active substance
The combination of netupitant and palonosetron is used for the prevention of chemotherapy-induced nausea and vomiting. Netupitant is an NK1 receptor antagonist, and palonosetron is a 5-HT3 receptor antagonist, both working to prevent nausea and vomiting.
The medication is taken orally, as directed by a doctor, usually one hour before the start of chemotherapy. It is important for patients to follow the treatment regimen to achieve maximum effectiveness.
Patients should be aware of potential side effects, such as headaches, constipation, or fatigue. It is important to inform the doctor of any unusual symptoms.
Common side effects include headaches, constipation, and fatigue. In rare cases, severe reactions such as allergic reactions or elevated liver enzyme levels may occur. Patients should be informed of these risks before use.
The medication is taken orally, as directed by a doctor, usually one hour before the start of chemotherapy. It is important for patients to follow the treatment regimen to achieve maximum effectiveness.
Patients should be aware of potential side effects, such as headaches, constipation, or fatigue. It is important to inform the doctor of any unusual symptoms.
Common side effects include headaches, constipation, and fatigue. In rare cases, severe reactions such as allergic reactions or elevated liver enzyme levels may occur. Patients should be informed of these risks before use.